STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CSBR CHAMPIONS ONCOLOGY INCORPORATED StockScouter® Report

8

StockScouter® Score

CHAMPIONS ONCOLOGY INCORPORATED, a small cap growth company in the healthcare sector, is expected to outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for a small company like CSBR
  • Moving average analysis for CSBR suggests flat price movement over the medium term. Neutral

 

Concerns

  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 100% done.
Low
High

Core Model Grades

N/A
C
C
A

Previous Ratings

7
7
6